Cytokeratin profiles in pituitary neuroendocrine tumors
Authors:
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 107, 87-95
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A High-Throughput Proteomic Approach Provides Distinct Signatures for Thyroid Cancer BehaviorClinical Cancer Research, 2011
- Anticytokeratin CAM5.2 is not Synonymous With CK8/18 Monoclonal Antibody; and Anticytokeratin CAM5.2 can be a Marker for Cytokeratin 8 but not for Cytokeratin 18 and 19American Journal of Surgical Pathology, 2010
- CAM5.2 Is Not Identical to Cytokeratins 8 and 18American Journal of Clinical Pathology, 2010
- Anti-Cytokeratin CAM 5.2 is Specific for K8 and to a Lesser Extent for the Closely Related K7, but Shows no Reactivity with K18 or K19Endocrine Pathology, 2010
- Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional FormEndocrine Pathology, 2008
- The Predictive Value of CK19 and CD99 in Pancreatic Endocrine TumorsAmerican Journal of Surgical Pathology, 2006
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Monoclonal antibody to cytokeratin for use in routine histopathology.Journal of Clinical Pathology, 1984
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsCell, 1982
- Change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenomaThe Journal of Pathology and Bacteriology, 1935